FDA pauses Regenxbio gene therapy trial again due to safety concerns Five patients were found to have small masses on their spines

https://www.statnews.com/2026/08/24/fda-pauses-regenxbio-gene-therapy-trial-hunter-syndrome-safety-concerns/ By Jason MastAug. 24, 2026 General Assignment Reporter